TABLE 5. Changes From Baseline for SCr and eGFR

	Iopamidol-370 Group		Iodixanol-320 Group		P^*
	N	Mean Change±SD	N	Mean Change±SD	P^*
*P value for comparison of contrast agent groups based on ANCOVA model.
Total population
SCr, mg/dL	204	0.07±0.22	210	0.12±0.23	0.032
eGFR, mL/min per 1.73 m²	204	−2.16±7.86	210	−4.02±8.10	0.038
Patients without diabetes mellitus
SCr, mg/dL	126	0.07±0.19	118	0.08±0.18	0.708
eGFR, mL/min per 1.73 m²	126	−2.23±7.18	118	−3.28±8.35	0.695
Patients with diabetes mellitus
SCr, mg/dL	78	0.07±0.26	92	0.16±0.27	0.013
eGFR, mL/min per 1.73 m²	78	−2.05±8.90	92	−4.97±7.65	0.016